Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Glucose-6-phosphate dehydrogenase deficiency screening
Introduction
Overview
Overview
G6PD defeciency screening in neonates is done routinly in some regions with high incidence.
Screening
Screening
- G6PD defeciency screening in neonates is done routinly in some regions with high incidence. [1]
- Screening test is quantitative laboratory assay for G6PD enzyme activity.
- Screening is done before giving oxidant medication to high risk patients.
- There is insufficient evidence to recommend routine screening for G6PD deficiency.
References
References
- ↑ Kaplan M, Hammerman C (February 2009). “The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective”. J Perinatol. 29 Suppl 1: S46–52. doi:10.1038/jp.2008.216. PMID 19177059.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]